ARHGDIA and cancer: For example, in human cancer cell lines ephrinB1 interacts with RhoGDI1 through its cytoplasmic domain which limits the activity of RhoA in the absence of ephrinB1 interaction with the EphB2 receptor (Cho et al., 2018).